Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 3
2010 1
2011 1
2013 1
2014 2
2015 3
2016 3
2017 4
2018 8
2019 9
2020 12
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Pandemrix™ and narcolepsy: A critical appraisal of the observational studies.
Verstraeten T, Cohet C, Dos Santos G, Ferreira GL, Bollaerts K, Bauchau V, Shinde V. Verstraeten T, et al. Among authors: bollaerts k. Hum Vaccin Immunother. 2016;12(1):187-93. doi: 10.1080/21645515.2015.1068486. Epub 2015 Sep 17. Hum Vaccin Immunother. 2016. PMID: 26379011 Free PMC article. Review.
Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project.
Van Baarle D, Bollaerts K, Del Giudice G, Lockhart S, Luxemburger C, Postma MJ, Timen A, Standaert B; Vaccines, Infectious Diseases in the Ageing Population (VITAL) consortium. Van Baarle D, et al. Among authors: bollaerts k. Vaccine. 2020 Aug 18;38(37):5896-5904. doi: 10.1016/j.vaccine.2020.07.005. Epub 2020 Jul 24. Vaccine. 2020. PMID: 32713682 Free PMC article. Review.
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
Meeraus W, de Munter L, Gray CM, Dwivedi A, Wyndham-Thomas C, Ouwens M, Hartig-Merkel W, Drikite L, Rebry G, Carmona A, Stuurman AL, Chi Nguyen TY, Mena G, Mira-Iglesias A, Icardi G, Otero-Romero S, Baumgartner S, Martin C, Taylor S, Bollaerts K. Meeraus W, et al. Among authors: bollaerts k. Lancet Reg Health Eur. 2023 Jul 1;31:100675. doi: 10.1016/j.lanepe.2023.100675. eCollection 2023 Aug. Lancet Reg Health Eur. 2023. PMID: 37547274 Free PMC article.
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.
Tin Tin Htar M, Stuurman AL, Ferreira G, Alicino C, Bollaerts K, Paganino C, Reinert RR, Schmitt HJ, Trucchi C, Vestraeten T, Ansaldi F. Tin Tin Htar M, et al. Among authors: bollaerts k. PLoS One. 2017 May 23;12(5):e0177985. doi: 10.1371/journal.pone.0177985. eCollection 2017. PLoS One. 2017. PMID: 28542347 Free PMC article. Review.
Childhood leukaemia near nuclear sites in Belgium, 2002-2008.
Bollaerts K, Simons K, Van Bladel L, De Smedt T, Sonck M, Fierens S, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, Van Nieuwenhuyse A. Bollaerts K, et al. Eur J Cancer Prev. 2018 Mar;27(2):184-191. doi: 10.1097/CEJ.0000000000000272. Eur J Cancer Prev. 2018. PMID: 27380513 Free PMC article.
Methodology for computing the burden of disease of adverse events following immunization.
McDonald SA, Nijsten D, Bollaerts K, Bauwens J, Praet N, van der Sande M, Bauchau V, de Smedt T, Sturkenboom M, Hahné S. McDonald SA, et al. Among authors: bollaerts k. Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):724-730. doi: 10.1002/pds.4419. Epub 2018 Mar 24. Pharmacoepidemiol Drug Saf. 2018. PMID: 29575242 Free PMC article.
44 results